Luspatercept in long term follow-up – Clinical Trial Open to Recruitment

Research FOR Patients
-For an informed and empowered opinion-

All the trials listed in our site have been properly vetted for scientific accuracy. Many thanks to Dr Simone Green – Hull and East Yorkshire Hospitals NHS Trust - for the continuous work in updating the listing.

Luspatercept in long term Follow up

  1. SUB-TYPE OF MDS:Low risk MDS patients who have participated in other Luspatercept clinical trials
  2. SEVERITY OF MDS: IPSS-R Very Low, Low or Intermediate Risk MDS
  3. NAME OF DRUG: Luspatercept
  4. Aims and benefits: To determine the long term safety of Luspatercept. This is a phase 3 single arm trial that is divided into 3 phases: the Transition Phase (period prior to enrollement into the study), Treatment Phase (for patients receiving Luspatercept treatment) and Follow-up Phase (Patients are observed for up to 5 years from start of Luspatercept or 3 years from the last dose of Luspatercept).
  5. Primary outcome:To determine adverse events over the period of observation as well as the incidence of disease progression and the development of other malignancies.
  6. Secondary outcome:To determine the overall survival in this patient group.

  1. Basic inclusion criteria:
    • Has been participating in a Luspatercept trial and continues to fulfill all the requirements of the parent protocol
    • Receiving Luspatercept and continues to receive clinical benefit OR Assigned to the Follow-up Phase of the parent protocol
  2. Basic exclusion criteria:
    • One or more criteria for study discontinuation as stipulated in the parent Luspatercept protocol.
    • Any significant medical condition, laboratory abnormality, psychiatric illness, or is considered vulnerable that would prevent the subject from participating in the study.
  3. Trial sites/locations and name of physician in charge of trial (none are currently recruiting):
    • Aberdeen Royal Infirmary
    • The Leeds Teaching Hospitals NHS Trust - St James's University Hospital
    • Barts Health NHS Trust - The Royal London Hospital
    • Whittington Hospital, London
    • University College London Hospitals NHS Foundation Trust - University College Hospital, London
    • Kings College Hospital, London
    • Oxford University Hospitals NHS Foundation Trust-Churchill Hospital-Cancer and Haematology Centre
    • Kings Mill Hospital, Sutton in Ashfield

Please read information and always discuss trial information with your own physician.

Free donations by shopping

Sign-up to Download our Free Patient Handbook!

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

MDS UK Patient Support Group will use the information you provide on this form to be in touch with you and to provide updates.